These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11392495)

  • 1. Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer.
    Price CP; Allard J; Davies G; Dawnay A; Duffy MJ; France M; Mandarino G; Ward AM; Patel B; Sibley P; Sturgeon C
    Ann Clin Biochem; 2001 May; 38(Pt 3):188-216. PubMed ID: 11392495
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen, clinical use and staging: an overview.
    Stenman UH
    Br J Urol; 1997 Mar; 79 Suppl 1():53-60. PubMed ID: 9088274
    [No Abstract]   [Full Text] [Related]  

  • 3. Percent free prostate-specific antigen: the next frontier in prostate-specific antigen testing.
    Beduschi MC; Oesterling JE
    Urology; 1998 May; 51(5A Suppl):98-109. PubMed ID: 9610564
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Clinical performance of serum isoform (-2)proPSA (p2PSA) and its derivatives, namely %p2PSA and PHI (Prostate Health Index) in men younger than 60 years of age: results from a multicentric European study.
    Taneja SS
    J Urol; 2014 Aug; 192(2):421. PubMed ID: 25034991
    [No Abstract]   [Full Text] [Related]  

  • 5. PSA and early prostate cancer detection: the importance of age-specific reference ranges.
    Oesterling JE
    Can J Oncol; 1994 Nov; 4 Suppl 1():52-6. PubMed ID: 8853490
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer.
    Veltri RW
    BJU Int; 2016 Jan; 117(1):12-3. PubMed ID: 26676682
    [No Abstract]   [Full Text] [Related]  

  • 7. [PSAD and PSA-AD in the early diagnosis of cancer of the prostate].
    Allepuz Losa C; Sanz JI; Carela J; Benejam J; García-Miralles R; Rioja Sanz LA
    Actas Urol Esp; 1997 Oct; 21(9):843-51. PubMed ID: 9471867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PSA volume quotient: an additional parameter in diagnosis of locally confined prostate cancer].
    Gottfried HW; Kleinschmidt K; Flohr P; Miller K; Hautmann R
    Urologe A; 1993 Nov; 32(6):455-9. PubMed ID: 7506850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSA scores: should we use a lower threshold?
    Carter HB
    Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):6. PubMed ID: 15602780
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate Cancer Screening.
    Eggener SE; Cifu AS; Nabhan C
    JAMA; 2015 Aug; 314(8):825-6. PubMed ID: 26305653
    [No Abstract]   [Full Text] [Related]  

  • 11. PSA: the plot thickens.
    Health News; 2003 Oct; 9(10):15. PubMed ID: 14619777
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prostate specific antigen].
    Koutani A; Lechevallier E; Coulange C
    Ann Urol (Paris); 1996; 30(5):257-61. PubMed ID: 8975592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prostate specific antigen acceleration for prostate cancer diagnosis.
    Benecchi L; Pieri AM; Pastizzaro CD; Potenzoni M
    J Urol; 2011 Mar; 185(3):821-6. PubMed ID: 21238998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verification bias and the prostate-specific antigen test--is there a case for a lower threshold for biopsy?
    Schröder FH; Kranse R
    N Engl J Med; 2003 Jul; 349(4):393-5. PubMed ID: 12878747
    [No Abstract]   [Full Text] [Related]  

  • 15. The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen.
    Herrmann W; Stöckle M; Sand-Hill M; Hübner U; Herrmann M; Obeid R; Wullich B; Loch T; Geisel J
    Clin Chem Lab Med; 2004; 42(9):1051-7. PubMed ID: 15497472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for prostatic cancer].
    Pushkar' DIu; Govorov AV; Bormotin AV
    Urologiia; 2003; (1):10-5. PubMed ID: 12621959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancer.
    Blijenberg BG; Bangma CH; Kranse R; Eman I; Schröder FH
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):111-4. PubMed ID: 9056753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment].
    Pushkar' DIu; Rasner PI; Skobelev PP
    Urologiia; 2001; (6):48-54. PubMed ID: 11785083
    [No Abstract]   [Full Text] [Related]  

  • 19. Some comments on progress in the standardization of immunoassays for prostate-specific antigen.
    Stamey TA
    Br J Urol; 1997 Mar; 79 Suppl 1():49-52. PubMed ID: 9088273
    [No Abstract]   [Full Text] [Related]  

  • 20. Should men be screened for prostate cancer?
    Patel SM
    N C Med J; 1999; 60(5):275-7. PubMed ID: 10495656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.